The most spoken research calls and the market move around Wall Street are NOW in one place. Here are today’s research calls that investors should know, as compiled by the fly.
-
Take advantage of Premium Tipranks at 55% reduction! Unlock powerful investment tools, advanced data and expert analyst information to help you invest with confidence.
Top 5 upgrades:
-
Wells Fargo has improved Amazon.com (AMZN) Bewelling weight equality with a price target of $ 280, compared to $ 245. Following its Cloud market and its analysis of anthropogenic contributions, Wells has increased Amazon’s web services will see the acceleration of income.
-
Morgan Stanley has improved Serve (Now) The overweight of equality of weight with a price target of $ 1,250, against $ 1,040. Morgan Stanley thinks that ServiceNow is well placed to offer AI generating capacities, creating an attractive risk / reward for actions.
-
UBS has upgraded General Motors (GM) to buy at neutral level with a price target of $ 81, compared to $ 56. Profits estimates in 2026 and 2027 of the company are respectively 35% and 42% above the consensus, because it estimates that the margins of North America GM can return to their target range from 8% to 10%.
-
Jefferies upgraded Quanta Services (PWR) to buy from Hold with a price target of $ 469, against $ 398. The current evaluation of the action, which withdrew from the summer summits, provides an attractive entry point, supports Jefferies.
-
Improved scotiabania OpenText (OTEX) To outperform the sector to carry out with a price target of $ 50, compared to $ 35. The company quotes increased conviction ”in the business management activities of the company for upgrading.
Top 5 declarations:
-
Morgan Stanley was demoted Adobe (ADBE) with an equal overweight weight with a price target of $ 450, compared to $ 520. The company believes that the deceleration of annual recurring income from the digital media of the company has created a “disproportionate” concern of its ability to prove that generative artificial intelligence is largely in its total opportunity.
-
Barclays was demoted Dr Pepper (KDP) at an equal overweight weight with a price target of $ 26, compared to $ 39. While the reshuffle of the company’s assets could be The good movement in the longer term, transactions “present a high noise and uncertainty over the next 12 months,” the company told investors in a research note
-
Jefferies downgraded Flower (Be) to underperform Hold with a price target of $ 31, compared to $ 24. The cabinet believes that the risks of sharing are downwards, given visibility limited to the growth of Bloom after 2026.
-
Susquehanna was demoted Knight (KNX) positive neutral with a price target of $ 43, compared to $ 52 as part of an overview of the third quarter profits for the logistics group and trucking. The company has reduced estimates in the sector, saying that prices and improvement of margins “remain in the distance”.
-
Bofa has been demoted Arvinas (ARVN) Neutral to buy with a price target of $ 10, against $ 16. The company quotes the company and Pfizer (PFE) announcing that they plan to find a partner to develop a drug against VEPDEG metastatic breast cancer.
